NEW YORK--(BUSINESS WIRE)--The Rome Foundation, which publishes the definitional criteria for over 40 functional gastrointestinal disorders (FGIDs), has partnered with MDCalc to make all of their criteria - including Rome IV - accessible to practicing clinicians at the bedside through MDCalc. MDCalc will be the official external provider of Rome criteria for all clinical use.
“Rome has created a structure for defining these GI syndromes properly, which has laid the foundation for the study and development of treatments that have helped millions and millions of patients. This would not have been possible without the Rome Foundation. We’re so excited to work with them to help even more patients by bringing their criteria to the bedside.” - Dr. Joseph Habboushe, Co-founder and CEO, MDCalc
“I was surprised when I googled the Rome criteria and MDCalc was the first search result. Then I found out they reach over two-thirds of physicians on a daily basis. We’re even more impressed with how they’ve found a way to respect and promote evidence-based medicine and continue to innovate clinical decision support. Bringing the Rome criteria to MDCalc combines two gold standards with only positive outcomes for improved patient care and enhances our work in GI.” Dr. Douglas Drossman, President Emeritus and COO, Rome Foundation
MDCalc is the gold standard for point-of-care clinical decision support tools and is used by millions of clinicians globally. It was founded by two practicing emergency physicians, Dr. Graham Walker and Dr. Joseph Habboushe, to improve clinical efficiency and patient outcomes. With over 550 calculators across 50+ specialties and expert content that undergo a rigorous validation process, MDCalc has become the leading resource for clinicians seeking evidence-based tools to drive better patient care.
Founded by Dr. Douglas Drossman, the Rome Foundation is an international organization that provides support for activities designed to create scientific data and educational information to assist in the diagnosis and treatment of Disorders of Gut Brain Interactions (DGBIs). Their mission is to improve the lives of people with functional GI disorders. They are committed to the continuous development, legitimization and preservation of the field of DGBIs through science-based activities.
ACG is the preeminent professional organization that champions the prevention, diagnosis, and treatment of digestive disorders by facilitating delivery of the highest quality, compassionate, and evidence-based patient care. MDCalc and ACG have partnered since 2018 to bring GI medical calculators and guidelines to the bedside.
